OTCMKTS:BAYRY - Bayer Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$17.74 -0.18 (-1.00 %)
(As of 11/19/2018 04:00 PM ET)
Previous Close$17.92
Today's Range$17.68 - $18.02
52-Week Range$17.74 - $33.86
Volume1.30 million shs
Average Volume783,456 shs
Market Capitalization$59.28 billion
P/E Ratio9.34
Dividend Yield3.17%
Beta1.11
Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, and cosmetics in the dermatology, nutritional supplement, analgesic, digestive health, allergy, cold, foot care, and sun protection categories. The Crop Science segment offers crop protection products, seeds, non-agriculture pest control products. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to vets, farmers, and pet-owners. Bayer Aktiengesellschaft has a collaboration agreement with The University of Texas MD Anderson Cancer Center to develop cancer treatments, as well as Haplogen GmbH. The company was founded in 1863 and is headquartered in Leverkusen, Germany.

Receive BAYRY News and Ratings via Email

Sign-up to receive the latest news and ratings for BAYRY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:BAYRY
Previous Symbol
CUSIPN/A
Phone49-21-4-30-1

Debt

Debt-to-Equity Ratio0.90
Current Ratio1.41
Quick Ratio1.00

Price-To-Earnings

Trailing P/E Ratio9.34
Forward P/E Ratio10.75
P/E Growth1.22

Sales & Book Value

Annual Sales$39.55 billion
Price / Sales1.48
Cash Flow$2.6320 per share
Price / Cash6.74
Book Value$12.60 per share
Price / Book1.41

Profitability

EPS (Most Recent Fiscal Year)$1.90
Net Income$8.29 billion
Net Margins15.58%
Return on Equity14.31%
Return on Assets6.10%

Miscellaneous

Employees99,820
Outstanding Shares3,307,800,000
Market Cap$59.28 billion
OptionableNot Optionable

Bayer (OTCMKTS:BAYRY) Frequently Asked Questions

What is Bayer's stock symbol?

Bayer trades on the OTCMKTS under the ticker symbol "BAYRY."

How often does Bayer pay dividends? What is the dividend yield for Bayer?

Bayer announced an annual dividend on Monday, March 19th. Shareholders of record on Tuesday, May 29th will be paid a dividend of $0.614 per share on Monday, June 11th. The ex-dividend date of this dividend is Friday, May 25th. View Bayer's Dividend History.

How were Bayer's earnings last quarter?

Bayer AG (OTCMKTS:BAYRY) issued its quarterly earnings results on Tuesday, November, 13th. The company reported $0.35 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.41 by $0.06. The business had revenue of $11.52 billion for the quarter, compared to the consensus estimate of $11.31 billion. Bayer had a net margin of 15.58% and a return on equity of 14.31%. View Bayer's Earnings History.

When is Bayer's next earnings date?

Bayer is scheduled to release their next quarterly earnings announcement on Wednesday, February 27th 2019. View Earnings Estimates for Bayer.

What is the consensus analysts' recommendation for Bayer?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bayer in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Bayer.

Has Bayer been receiving favorable news coverage?

Press coverage about BAYRY stock has been trending somewhat positive on Monday, InfoTrie reports. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Bayer earned a media sentiment score of 0.9 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 9.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the near future.

Who are some of Bayer's key competitors?

Who are Bayer's key executives?

Bayer's management team includes the folowing people:
  • Mr. Werner Baumann, Chairman of Management & CEO (Age 56)
  • Mr. Liam Condon, CEO & Pres of Bayer Cropscience and Member of Management Board (Age 50)
  • Dr. Kemal Malik, Head of Innovation & Member of Management Board (Age 56)
  • Dr. Hartmut Klusik, Head of HR, Technology & Sustainability, Labor Director and Member of Management Board (Age 62)
  • Mr. Dieter Weinand, Head of the Pharmaceuticals Division & Member of Management Board (Age 58)

How do I buy shares of Bayer?

Shares of BAYRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bayer's stock price today?

One share of BAYRY stock can currently be purchased for approximately $17.8040.

How big of a company is Bayer?

Bayer has a market capitalization of $59.28 billion and generates $39.55 billion in revenue each year. The company earns $8.29 billion in net income (profit) each year or $1.90 on an earnings per share basis. Bayer employs 99,820 workers across the globe.

What is Bayer's official website?

The official website for Bayer is http://www.bayer.com.

How can I contact Bayer?

Bayer's mailing address is Kaiser-Wilhelm-Allee 1, Leverkusen 2M, 51368. The company can be reached via phone at 49-21-4-30-1 or via email at [email protected]


MarketBeat Community Rating for Bayer (OTCMKTS BAYRY)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  262 (Vote Outperform)
Underperform Votes:  310 (Vote Underperform)
Total Votes:  572
MarketBeat's community ratings are surveys of what our community members think about Bayer and other stocks. Vote "Outperform" if you believe BAYRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAYRY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/19/2018 by MarketBeat.com Staff

Featured Article: Dividend

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel